New York City hospitals drop Palantir as controversial AI firm expands in UK

Editor's take

New York City's public hospital system has terminated its contract with Palantir, citing concerns that led to activist pressure. This move signals a growing hesitancy among some institutions to engage with Palantir's data-analysis platforms, particularly in sensitive sectors like healthcare, amidst intensifying scrutiny of its work with the UK's National Health Service and government.

The significance lies in Palantir's persistent efforts to secure large-scale public sector contracts, which are crucial for its revenue growth and public perception. The NYC decision, following similar concerns raised by privacy advocates regarding the UK's NHS AI Lab and its £330 million deal, suggests a potential challenge for Palantir in replicating its US government successes in a more privacy-conscious European market.

Future attention should focus on whether other US cities or healthcare networks follow suit, and how Palantir adapts its strategy to address these ethical and privacy-related objections. The success of its UK ventures, particularly its £1.7 billion NHS deal, will be a key indicator of its ability to navigate these complex regulatory and public opinion landscapes.